Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-01-10 Sale |
2022-01-11 8:21 pm |
Olema Pharmaceuticals Inc. | OLMA | Horn Kinney CHIEF BUSINESS OFFICER |
5,251 | $6.85 | $35,969 | 154,747 (Direct) |
View |
| 2021-12-10 Sale |
2021-12-14 4:25 pm |
Olema Pharmaceuticals Inc. | OLMA | Horn Kinney CHIEF BUSINESS OFFICER |
5,251 | $10.39 | $54,558 | 159,998 (Direct) |
View |
| 2021-12-10 Sale |
2021-12-14 4:03 pm |
Olema Pharmaceuticals Inc. | OLMA | Myles David C. CHIEF DEVELOPMENT OFFICER |
10,000 | $10.3 | $103,000 | 750,578 (Indirect Direct) |
View |
| 2021-11-30 Purchase |
2021-12-02 8:45 pm |
Olema Pharmaceuticals Inc. | OLMA | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BVF I GP LLC BIOTECHNOLOGY VALUE FUND II LP BVF II GP LLC Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF GP HOLDINGS LLC BVF INC LAMPERT MARK N Director 10% Owner |
739,675 | $9.3903 | $6,945,770 | 557,430 (Indirect Direct) |
View |
| 2021-11-29 Sale |
2021-12-01 5:34 pm |
Olema Pharmaceuticals Inc. | OLMA | Harmon Cyrus CHIEF TECHNOLOGY OFFICER |
400 | $24.76 | $9,904 | 1,173,174 (Indirect Direct) |
View |
| 2021-11-10 Sale |
2021-11-12 5:15 pm |
Olema Pharmaceuticals Inc. | OLMA | Horn Kinney CHIEF BUSINESS OFFICER |
27,668 | $26.88 | $743,716 | 231,834 (Direct) |
View |
| 2021-10-19 Sale |
2021-10-21 4:33 pm |
Olema Pharmaceuticals Inc. | OLMA | Harmon Cyrus CHIEF TECHNOLOGY OFFICER |
12,000 | $27.98 | $335,794 | 1,173,574 (Indirect Direct) |
View |
| 2021-10-14 Sale |
2021-10-15 6:44 pm |
Olema Pharmaceuticals Inc. | OLMA | Bohen Sean PRESIDENT AND CEO |
5,000 | $30.47 | $152,363 | 1,018,830 (Direct) |
View |
| 2021-10-11 Sale |
2021-10-12 6:53 pm |
Olema Pharmaceuticals Inc. | OLMA | Horn Kinney CHIEF BUSINESS OFFICER |
5,251 | $27.9 | $146,510 | 169,832 (Direct) |
View |
| 2021-09-27 Sale |
2021-09-29 7:56 pm |
Olema Pharmaceuticals Inc. | OLMA | Bohen Sean PRESIDENT AND CEO |
1,085 | $30.07 | $32,626 | 1,023,830 (Direct) |
View |
| 2021-09-20 Sale |
2021-09-21 6:19 pm |
Olema Pharmaceuticals Inc. | OLMA | Harmon Cyrus CHIEF TECHNOLOGY OFFICER |
12,000 | $26.3 | $315,600 | 1,185,574 (Indirect Direct) |
View |
| 2021-09-10 Sale |
2021-09-13 8:07 pm |
Olema Pharmaceuticals Inc. | OLMA | Horn Kinney CHIEF BUSINESS OFFICER |
5,251 | $29.38 | $154,274 | 175,083 (Direct) |
View |
| 2021-09-07 Sale |
2021-09-09 4:25 pm |
Olema Pharmaceuticals Inc. | OLMA | Bohen Sean PRESIDENT AND CEO |
3,044 | $30.01 | $91,353 | 1,999,947 (Direct) |
View |
| 2021-09-01 Sale |
2021-09-03 5:16 pm |
Olema Pharmaceuticals Inc. | OLMA | Bohen Sean PRESIDENT AND CEO |
871 | $30.05 | $26,174 | 1,029,719 (Direct) |
View |
| 2021-08-19 Sale |
2021-08-20 9:14 pm |
Olema Pharmaceuticals Inc. | OLMA | Harmon Cyrus CHIEF TECHNOLOGY OFFICER |
12,000 | $24.97 | $299,640 | 1,197,574 (Indirect Direct) |
View |
| 2021-08-10 Sale |
2021-08-11 6:05 pm |
Olema Pharmaceuticals Inc. | OLMA | Horn Kinney CHIEF BUSINESS OFFICER |
5,251 | $25.71 | $134,979 | 180,334 (Direct) |
View |
| 2021-07-19 Sale |
2021-07-21 5:29 pm |
Olema Pharmaceuticals Inc. | OLMA | Harmon Cyrus CHIEF TECHNOLOGY OFFICER |
12,000 | $25.1 | $301,258 | 1,209,574 (Indirect Direct) |
View |
| 2021-07-12 Sale |
2021-07-13 6:27 pm |
Olema Pharmaceuticals Inc. | OLMA | Horn Kinney CHIEF BUSINESS OFFICER |
5,251 | $26.51 | $139,191 | 185,585 (Direct) |
View |
| 2021-06-18 Sale |
2021-06-21 7:05 pm |
Olema Pharmaceuticals Inc. | OLMA | Harmon Cyrus CHIEF TECHNOLOGY OFFICER |
12,000 | $24.8 | $297,626 | 1,099,546 (Direct) |
View |
| 2021-06-10 Sale |
2021-06-11 4:30 pm |
Olema Pharmaceuticals Inc. | OLMA | Horn Kinney CHIEF BUSINESS OFFICER |
5,251 | $29.72 | $156,071 | 190,836 (Direct) |
View |
| 2021-05-18 Sale |
2021-05-19 8:18 pm |
Olema Pharmaceuticals Inc. | OLMA | Horn Kinney CHIEF BUSINESS OFFICER |
57,763 | $24.15 | $1,394,769 | 196,087 (Direct) |
View |
| 2020-11-23 Purchase |
2020-11-23 4:59 pm |
Olema Pharmaceuticals Inc. | OLMA | Cormorant Asset Management LP Chen Bihua Cormorant Global Healthcare Master Fund LP Cormorant Private Healthcare Fund II LP Cormorant Private Healthcare Fund III LP Former 10% Owner |
425,000 | $19 | $8,075,000 | 3,270,544 (Indirect) |
View |
| 2020-11-23 Purchase |
2020-11-23 4:35 pm |
Olema Pharmaceuticals Inc. | OLMA | Graham G. Walmsley Director |
1,160,000 | $19 | $22,040,000 | 1,160,000 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2022-02-01 Option Award |
2022-02-03 6:59 pm |
N/A 2032-01-31 |
Olema Pharmaceuticals Inc. | OLMA | Zojwalla Naseem CHIEF MEDICAL OFFICER |
250,000 | $0 | 250,000 (Direct) |
View |
| 2022-01-10 Exercise |
2022-01-11 8:21 pm |
N/A 2030-06-09 |
Olema Pharmaceuticals Inc. | OLMA | Horn Kinney CHIEF BUSINESS OFFICER |
5,251 | $0 | 154,747 (Direct) |
View |
| 2022-01-10 Exercise |
2022-01-11 8:21 pm |
N/A N/A |
Olema Pharmaceuticals Inc. | OLMA | Horn Kinney CHIEF BUSINESS OFFICER |
5,251 | $2.064 | 154,747 (Direct) |
View |
| 2021-12-10 Exercise |
2021-12-14 4:25 pm |
N/A 2030-06-09 |
Olema Pharmaceuticals Inc. | OLMA | Horn Kinney CHIEF BUSINESS OFFICER |
5,251 | $0 | 159,998 (Direct) |
View |
| 2021-12-10 Exercise |
2021-12-14 4:25 pm |
N/A N/A |
Olema Pharmaceuticals Inc. | OLMA | Horn Kinney CHIEF BUSINESS OFFICER |
5,251 | $2.064 | 159,998 (Direct) |
View |
| 2021-11-10 Exercise |
2021-11-12 5:15 pm |
N/A 2030-06-09 |
Olema Pharmaceuticals Inc. | OLMA | Horn Kinney CHIEF BUSINESS OFFICER |
27,668 | $0 | 231,834 (Direct) |
View |
| 2021-11-10 Exercise |
2021-11-12 5:15 pm |
N/A N/A |
Olema Pharmaceuticals Inc. | OLMA | Horn Kinney CHIEF BUSINESS OFFICER |
5,251 | $2.064 | 231,834 (Direct) |
View |
| 2021-11-10 Exercise |
2021-11-12 5:15 pm |
N/A N/A |
Olema Pharmaceuticals Inc. | OLMA | Horn Kinney CHIEF BUSINESS OFFICER |
22,417 | $19 | 231,834 (Direct) |
View |
| 2021-10-14 Exercise |
2021-10-15 6:44 pm |
N/A N/A |
Olema Pharmaceuticals Inc. | OLMA | Bohen Sean PRESIDENT AND CEO |
5,000 | $4.824 | 1,018,830 (Direct) |
View |
| 2021-10-14 Exercise |
2021-10-15 6:44 pm |
N/A 2030-11-18 |
Olema Pharmaceuticals Inc. | OLMA | Bohen Sean PRESIDENT AND CEO |
5,000 | $0 | 1,018,830 (Direct) |
View |
| 2021-10-11 Exercise |
2021-10-12 6:53 pm |
N/A 2030-06-09 |
Olema Pharmaceuticals Inc. | OLMA | Horn Kinney CHIEF BUSINESS OFFICER |
5,251 | $0 | 169,832 (Direct) |
View |
| 2021-10-11 Exercise |
2021-10-12 6:53 pm |
N/A N/A |
Olema Pharmaceuticals Inc. | OLMA | Horn Kinney CHIEF BUSINESS OFFICER |
5,251 | $2.064 | 169,832 (Direct) |
View |
| 2021-09-27 Exercise |
2021-09-29 7:56 pm |
N/A N/A |
Olema Pharmaceuticals Inc. | OLMA | Bohen Sean PRESIDENT AND CEO |
1,085 | $4.824 | 1,023,830 (Direct) |
View |
| 2021-09-27 Exercise |
2021-09-29 7:56 pm |
N/A 2030-11-18 |
Olema Pharmaceuticals Inc. | OLMA | Bohen Sean PRESIDENT AND CEO |
1,085 | $0 | 1,023,830 (Direct) |
View |
| 2021-09-10 Exercise |
2021-09-13 8:07 pm |
N/A 2030-06-09 |
Olema Pharmaceuticals Inc. | OLMA | Horn Kinney CHIEF BUSINESS OFFICER |
5,251 | $0 | 175,083 (Direct) |
View |
| 2021-09-10 Exercise |
2021-09-13 8:07 pm |
N/A N/A |
Olema Pharmaceuticals Inc. | OLMA | Horn Kinney CHIEF BUSINESS OFFICER |
5,251 | $2.064 | 175,083 (Direct) |
View |
| 2021-09-07 Exercise |
2021-09-09 4:25 pm |
N/A N/A |
Olema Pharmaceuticals Inc. | OLMA | Bohen Sean PRESIDENT AND CEO |
3,044 | $4.824 | 1,999,947 (Direct) |
View |
| 2021-09-07 Exercise |
2021-09-09 4:25 pm |
N/A 2030-11-18 |
Olema Pharmaceuticals Inc. | OLMA | Bohen Sean PRESIDENT AND CEO |
3,044 | $0 | 1,999,947 (Direct) |
View |
| 2021-09-01 Exercise |
2021-09-03 5:16 pm |
N/A N/A |
Olema Pharmaceuticals Inc. | OLMA | Bohen Sean PRESIDENT AND CEO |
871 | $4.824 | 1,029,719 (Direct) |
View |
| 2021-09-01 Exercise |
2021-09-03 5:16 pm |
N/A 2030-11-18 |
Olema Pharmaceuticals Inc. | OLMA | Bohen Sean PRESIDENT AND CEO |
871 | $0 | 1,029,719 (Direct) |
View |
| 2021-08-10 Exercise |
2021-08-11 6:05 pm |
N/A 2030-06-09 |
Olema Pharmaceuticals Inc. | OLMA | Horn Kinney CHIEF BUSINESS OFFICER |
5,251 | $0 | 180,334 (Direct) |
View |
| 2021-08-10 Exercise |
2021-08-11 6:05 pm |
N/A N/A |
Olema Pharmaceuticals Inc. | OLMA | Horn Kinney CHIEF BUSINESS OFFICER |
5,251 | $2.064 | 180,334 (Direct) |
View |
| 2021-07-12 Exercise |
2021-07-13 6:27 pm |
N/A 2030-06-09 |
Olema Pharmaceuticals Inc. | OLMA | Horn Kinney CHIEF BUSINESS OFFICER |
5,251 | $0 | 185,585 (Direct) |
View |
| 2021-07-12 Exercise |
2021-07-13 6:27 pm |
N/A N/A |
Olema Pharmaceuticals Inc. | OLMA | Horn Kinney CHIEF BUSINESS OFFICER |
5,251 | $2.064 | 185,585 (Direct) |
View |
| 2021-06-10 Exercise |
2021-06-11 4:30 pm |
N/A 2030-06-09 |
Olema Pharmaceuticals Inc. | OLMA | Horn Kinney CHIEF BUSINESS OFFICER |
5,251 | $0 | 190,836 (Direct) |
View |
| 2021-06-10 Exercise |
2021-06-11 4:30 pm |
N/A N/A |
Olema Pharmaceuticals Inc. | OLMA | Horn Kinney CHIEF BUSINESS OFFICER |
5,251 | $2.064 | 190,836 (Direct) |
View |
| 2021-06-09 Option Award |
2021-06-10 6:43 pm |
N/A 2031-06-08 |
Olema Pharmaceuticals Inc. | OLMA | Hrustanovic Gorjan Director |
21,520 | $0 | 21,520 (Direct) |
View |
| 2021-06-09 Option Award |
2021-06-10 6:40 pm |
N/A 2031-06-08 |
Olema Pharmaceuticals Inc. | OLMA | CLARK IAN T Director |
21,520 | $0 | 21,520 (Direct) |
View |
| 2021-06-09 Option Award |
2021-06-10 6:39 pm |
N/A 2031-06-08 |
Olema Pharmaceuticals Inc. | OLMA | Horning Sandra Director |
21,520 | $0 | 21,520 (Direct) |
View |
| 2021-06-09 Option Award |
2021-06-10 6:38 pm |
N/A 2031-06-08 |
Olema Pharmaceuticals Inc. | OLMA | Graham G. Walmsley Director |
21,520 | $0 | 21,520 (Direct) |
View |
| 2021-06-09 Option Award |
2021-06-10 6:36 pm |
N/A 2031-06-08 |
Olema Pharmaceuticals Inc. | OLMA | BUTITTA CYNTHIA M Director |
21,520 | $0 | 21,520 (Direct) |
View |
| 2021-06-09 Option Award |
2021-06-10 6:36 pm |
N/A 2031-06-08 |
Olema Pharmaceuticals Inc. | OLMA | Larson Yi Director |
21,520 | $0 | 21,520 (Direct) |
View |
| 2021-06-09 Option Award |
2021-06-10 6:35 pm |
N/A 2031-06-08 |
Olema Pharmaceuticals Inc. | OLMA | RAPPAPORT ANDREW Director |
21,520 | $0 | 21,520 (Direct) |
View |
| 2021-03-31 Other |
2021-05-26 9:37 pm |
N/A N/A |
Olema Pharmaceuticals Inc. | OLMA | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BVF I GP LLC BIOTECHNOLOGY VALUE FUND II LP BVF II GP LLC Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF GP HOLDINGS LLC BVF INC LAMPERT MARK N Director 10% Owner |
99,556 | $0 | 6,615,682 (Indirect) |
View |
| 2021-05-18 Exercise |
2021-05-19 8:18 pm |
N/A 2030-06-09 |
Olema Pharmaceuticals Inc. | OLMA | Horn Kinney CHIEF BUSINESS OFFICER |
57,763 | $0 | 196,087 (Direct) |
View |
| 2021-05-18 Exercise |
2021-05-19 8:18 pm |
N/A N/A |
Olema Pharmaceuticals Inc. | OLMA | Horn Kinney CHIEF BUSINESS OFFICER |
57,763 | $2.064 | 196,087 (Direct) |
View |
| 2021-04-05 Option Award |
2021-04-06 7:49 pm |
N/A 2031-04-04 |
Olema Pharmaceuticals Inc. | OLMA | Larson Yi Director |
25,293 | $0 | 25,293 (Direct) |
View |
| 2021-03-15 Option Award |
2021-03-16 7:07 pm |
N/A 2031-03-14 |
Olema Pharmaceuticals Inc. | OLMA | Horn Kinney Chief Business Officer |
40,000 | $0 | 40,000 (Direct) |
View |
| 2021-03-15 Option Award |
2021-03-16 7:05 pm |
N/A 2031-03-14 |
Olema Pharmaceuticals Inc. | OLMA | Bohen Sean President and CEO |
75,000 | $0 | 75,000 (Direct) |
View |
| 2020-11-23 Conversion |
2020-11-24 5:36 pm |
N/A N/A |
Olema Pharmaceuticals Inc. | OLMA | Wellington Biomedical Innovation Master Investors (Cayman) I L.P. 10% Owner |
1,725,406 | $0 | 1,725,406 (Direct) |
View |
| 2020-11-23 Conversion |
2020-11-23 4:59 pm |
N/A N/A |
Olema Pharmaceuticals Inc. | OLMA | Cormorant Asset Management LP Chen Bihua Cormorant Global Healthcare Master Fund LP Cormorant Private Healthcare Fund II LP Cormorant Private Healthcare Fund III LP Former 10% Owner |
5,691,088 | $0 | 3,270,544 (Indirect) |
View |
| 2020-11-23 Conversion |
2020-11-23 4:35 pm |
N/A N/A |
Olema Pharmaceuticals Inc. | OLMA | Graham G. Walmsley Director |
2,583,875 | $0 | 1,160,000 (Indirect) |
View |
| 2020-11-23 Conversion |
2020-11-23 4:35 pm |
N/A N/A |
Olema Pharmaceuticals Inc. | OLMA | RAPPAPORT ANDREW Director |
448,556 | $0 | 481,014 (Indirect) |
View |
| 2020-11-23 Conversion |
2020-11-23 4:34 pm |
N/A N/A |
Olema Pharmaceuticals Inc. | OLMA | Myles David C. Chief Development Officer |
167,677 | $0 | 746,667 (Indirect) |
View |